Ulcerative colitis: open trials in Jordan

• NCT07652294

  Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

  Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.

  Amman · Amman · Irbid · Irbid

  Registry updated 2026-11-03

• NCT06619990

  Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  Trial Treatment · Phase 1/2 · Xencor, Inc.

  Amman · Irbid

  Registry updated 2026-10-30

• NCT07012395

  A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.

  Amman · Amman · Amman · Irbid · Irbid · Irbid

  Registry updated 2026-10-27

• NCT06850727

  Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

  Trial Treatment · Phase 2 · Odyssey Therapeutics, Inc.

  Jordan University Hospital, Amman · The Specialty Hospital (TSH) / Advanced Clinical Center, Amman · Irbid Specialty Hospital, Irbid

  Registry updated 2026-02-11

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error